News & Events

Entry Into a Material Definitive Agreement On August 7, 2025, BioVie Inc. (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with ThinkEquity LLC, as the sole underwriter (the “ Underwriter ”), in connection with the issuance and sale (the “ Offering ”) of 5,620,000 units (the “ Units ”) and 380,000 pre-funded units (the “ Pre-Funded Units ”), resulting in net proceeds of approximately $10.4 million, after deducting underwriting discounts and commissions…

The offer and sale of the Underwriter’s Warrants have not been registered under the Securities Act and were instead offered pursuant to the exemption provided in Section 4(a)(2) under the Securities Act and/or Rule 506(b) promulgated thereunder. The Underwriter’s Warrants and the shares of Common Stock underlying the Underwriter’s Warrants may not be offered or sold in the United States absent registration or an exemption from registration under the Securities Act and any applicable state sec…

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On July 17, 2025, the Board of Directors (the “Board”) of BioVie Inc. (the “Company”) increased the size of the Board from four (4) to six (6) directors and appointed Amy S. Chappell, MD, FAAN, and Kameel D. Farag to the Board, effective immediately. There is no arrangement or understanding between either of Dr. Chappell or Mr. Farag and any other…

Material Modification to Rights of Security Holders. As previously reported, at a special meeting of stockholders of BioVie Inc. ( the “Company”) held on June 23, 2025 (the “Special Meeting”), the Company’s stockholders approved a proposal authorizing the board of directors of the Company (the “Board”), in its sole discretion, prior to the one-year anniversary of the Special Meeting, to effect a reverse stock split of the outstanding shares of the Company’s Class A common stock (“Common Stock…

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 28, 2025, Dr. Robert Hariri informed BioVie Inc. (the “Company”) of his decision to resign from the Board of Directors of the Company (the “Board”), effective as of such date. His resignation did not result from any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. Dr. Hariri joined th…